Clinical Trial Update: Liposomal Bupivacaine + Bupivacaine vs. Bupivacaine Alone on Opioid Use After Elective c/Section [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing liposomal bupivacaine plus bupivacaine to bupivacaine alone for postoperative opioid use after cesarean section has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cesarean Section
• Postoperative Pain

Drugs mentioned

• Bupivacaine (Bupivacaine)
• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Postoperative Pain, Cesarean Section | Phase 4 | Status: WITHDRAWN